Pre-therapeutic dosimetry and biodistribution of 86Y-DOTAPhe( 1)-Tyr(3)-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours - Helisch, A; Förster, GJ; Reber, H (Eur J Nucl Med Mol Imaging, 2004)